Frontotemporal lobar degeneration - Tau as a pied piper?

Neurogenetics

Volumn 4, Issue 2, 2002, Pages 63-75

  Tolnay, Markus ^a,b   Probst, Alphonse ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Frontotemporal dementia; FTDP 17; Motor neuron disease; Tauopathy; Ubiquitin

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; CHROMOSOME 17; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FRONTOTEMPORAL DEMENTIA; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

BRAIN; DEMENTIA; HUMANS; TAU PROTEINS;

EID: 0036819090     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-002-0140-x     Document Type: Review

References (125)

1. Lowe J (1997) Degenerative non-Alzheimer dementias. Brain Pathol 7:1047-1051
2. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RAI de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB International Workshop. Neurology 47: 1113-1124
3. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 51:1546-1554
4. Foster NL, Wilhelmsen K, Sima AAF, Johnes MZ, D'Amato CJ, Gilman S, Spillantini MG, Lynch T, Mayeux RP, Gaskell P-C, Hulette C, Pericak-Vance MA, Welsh-Bohmer KA, Dickson DW, Heutink P, Kros J, Swieten JC van, Arwert F, Ghetti B, Murell J, Lannfelt L, Hutton M, Phelps CH, Snyder DS, Oliver E, Ball MJ, Cummings JL, Miller BL, Katzman R, Reed L, Schelper RL, Lanska DJ, Brun A, Fink JK, Khul DE, Knopman DS, Wszolek Z, Miller CL, Bird TD, Lendon C, Elechi C (1997) Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Ann Neurol 41:706-715
5. Tolnay M, Probst A (1999) Review: Tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol 25:171-187
6. Lee VM-L, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159
7. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD (2001) Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 58:383-387
8. Mann DMA, McDonagh AM, Snowden J, Neary D, Pickering-Brown SM (2000) Molecular classification of the dementias. Lancet 355:626
9. Spillantini MG, Van Swieten JC, Goedert M (2000) Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2:193-205
10. Perry RJ, Hodges JR (2000) Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 54:2277-2284
11. The Lund and Manchester Groups (1994) Consensus statement: Clinical and neuropathological criteria for fronto-temporal dementia. J Neurol Neurosurg Psychiatry 4:416-418
12. McKhann GM, Albert MS, Grossman M. Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia. Report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol 58: 1803-1809
13. Snowden JS, Neary D, Mann DMA (1996) Frontotemporal Lobar Degeneration: Frontotemporal Dementia, Progressive Aphasia, Semantic Dementia. Churchill Livingstone, London
14. Snowden JS, Goulding PJ, Neary D (1989) Semantic dementia: A form of circumscribed cerebral atrophy. Behav Neurol 2:167-182
15. Hodges JR, Patterson K, Oxbury S, Funnell E (1992) Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 115:1783-1806
16. Mesulam MM (1982) Slowly progressive aphasia without generalized dementia. Ann Neurol 11:592-598
17. Weintraub S, Rubin NP, Mesulam MM J (1990) Primary progressive aphasia: Longitudinal course, neuropsychological profile and language features. Arch Neurol 47: 1329-1335
18. Snowden JS, Neary D, Mann DMA, Goulding PJ, Testa HJ (1992) Progressive language disorder due to lobar atrophy. Ann Neurol 31:174-183
19. Mesulam MM (2001) Primary progressive aphasia. Ann Neurol 49:425-432
20. Kertesz A, Davidson W, Munoz DG (1999) Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: The Pick complex. Dement Geriatr Cogn Disord 10 [Suppl 1]:46-49
21. Pick A (1982) Ueber die beziehungen der senilen hirnatrophie zur aphasie. Prager Med Wochenschr 17:165-167
22. Pick A (1901) Senile hirnatrophie als grundlage von herderscheinungen. Wien Klin Wochenschr 14:403-404
23. Pick A (1904) Zur symptomatologie der linksseitigen schläfenlappenatrophie. Monatschr Psychiatr Neurol 16:378-388
24. Alzheimer A (1911) Ueber eigenartige krankheitsfälle des späteren alters. Z Gesamte Neurol Psychiatr 4:356-385
25. Altman E (1923) Ueber die umschriebene gehirnatrophie des späteren alters. Z Gesamt Neurol Psychiatr 83:610-643
26. Onari K, Spatz H (1926) Anatomische beiträge zur lehre von der pickschen umschriebenen grosshirnrinden-atrophie ("picksche krankheit"). Z Gesamte Neurol Psychiatr 101: 470-511
27. Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG (1996) Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol (Berl) 92:588-596
28. Delacourte A, Robitaille Y, Sergeant N, Buée L, Hof PR, Wattez A, Laroche-Cholette A, Mathieu J, Chagnon P, Gauvreau D (1996) Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 55: 159-168
29. Ikeda K, Akiyama H, Arai T, Nishimura T (1998) Glial tau pathology in neurodegenerative diseases: Their nature and comparison with neuronal tangles. Neurobiol Aging 19 [Suppl 1]:85-91
30. Buée L, Delacourte A (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 9:681-693
31. Dickson DW (1998) Pick's disease: A modern approach. Brain Pathol 8:339-354
32. Rebeiz J, Kolodny EH, Richardson EP Jr (1967) Corticodentatonigral degeneration with neuronal achromasia: A progressive disorder in late adult life. Trans Am Neurol Assoc 92:23-26
33. Rebeiz J, Kolodny EH, Richardson EP Jr (1968) Corticodentatonigral degeneration with neuronal achromasia 2. Arch Neurol 18:20-33
34. Grimes DA, Lang AE, Bergeron CB (1999) Dementia as the most common presentation of cortical-basal ganglionic degeneration. Neurology 53:1969-1974
35. Mathuranath PS, Xuereb JH, Bak T, Hodges JR (2000) Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature. J Neurol Neurosurg Psychiatry 68:304-312
36. Kertesz A, Davidson W, Munoz DG (1999) Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: The Pick complex. Dement Geriatr Cogn Disord 10 [Suppl 1]:46-49
37. Feany MB, Dickson DW (1995) Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol 146:1388-1396
38. Komori T (1999) Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9:663-679
39. Komori T, Arai N, Oda H, Nakayama H, Mori H, Yagishita S, Takahashi T, Amano N, Murayama S, Murakami S, Shibata N, Kobayashi M, Sasaki S, Iwata M (1998) Astrocytic plaques and tufts of abnormal fibres do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 96:401-408
40. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. Arch Neurol 10:333-359
41. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47:1-9
42. Litvan I (2001) Diagnosis and management of progressive supranuclear palsy. Semin Neurol 21:41-48
43. Verny M, Jellinger KA, Hauw JJ, Bancher C, Litvan I, Agid Y (1996) Progressive supranuclear palsy: A clinicopathological study of 21 cases. Acta Neuropathol (Berl) 91:427-431
44. Verny M, Duyckaerts C, Agid Y, Hauw JJ (1996) The significance of cortical pathology in progressive supranuclear palsy. Clinicopathological data in 10 cases. Brain 119:1123-1136
45. Bergeron C, Davis A, Lang AE (1998) Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 8:355-365
46. Hauw JJ, Daniel SE, Dickson D, Horoupian DS, Jellinger K, Lantos PL, McKee A, Tabaton M, Litvan I. (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44:2015-2019
47. Probst A, Langui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH (1988) Progressive supranuclear palsy: Extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol (Berl) 77:61-68
48. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-A31
49. Ronald and Nancy Reagan Institute of the Alzheimer's Association and National Institute on Aging Working Group on Biological Markers of Alzheimer's Disease (1998) Consensus report of the Working Group on Molecular and Biochemical Markers of Alzheimer's Disease. Neurobiol Aging 19:109-116
50. Jobst KA, Barnetson LP, Shepstone BJ (1998) Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: The use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray, and Apo E4 in medial temporal lobe dementias. Oxford project to investigate memory and aging. Int Psychogeriatr 10:271-302
51. Miller BL, Ikonte C, Ponton M, Levy M, Boone K, Darby A, Berman N, Mena I, Cummings JL (1997) A study of the Lund-Manchester research criteria for frontotemporal dementia: Clinical and single-photon emission CT correlations. Neurology 48:937-942.
52. Kramer JH, Miller BL (2000) Alzheimer's disease and its focal variants. Semin Neurol 20:447-454
53. Johnson JK, Head E, Kim R, Starr A, Cotman CW (1999) Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch Neurol 56:1233-1239
54. Wilhelmsen KC, Lynch T, Pavlou E, Higgins M, Nygaard TG (1994) Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am J Hum Genet 55: 1159-1165
55. Swieten JC Van, Stevens M, Rosso SM, Rizzu P, Joosse M, Koning I de, Kamphorst W, Ravid R, Spillantini MG, Niermeijer MF, Heutink P (1999) Phenotypic variation in hereditary frontotemporal dementia with tau mutations. Ann Neurol 46:617-626
56. Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, Wood N, Khan MN, Cipolotti L, Fox NC, Rossor MN (2002) Clinical features of frontotemporal dementia due to the intronic tau 10 (+16) mutation. Neurology 58:1161-1168
57. Spillantini MG, Bird TD, Ghetti B (1998) Frontotemporal dementia and parkinsonism linked to chromosome 17: A new group of tauopathies. Brain Pathol 8:387-402
58. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815-825
59. Spillantini MG, Murell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95:7737-7741
60. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davis P, Petersen RC, Stevens M, Graaf E de, Wauters E, Baren J van, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Che LK, Norton J, Morris JC, Reed LA, Trojanowski J, Basun H, Lannfelt L, Neystat M, Fahn S, Dark F, Tannenberg T, Dodd PR, Hayward N, Kwok JBJ, Schofield PR, Andreadis A, Snowden J, Craufurd D, Neary D, Owen F, Oostra BA, Hardy J, Goate A, Swieten J Van, Mann D, Lynch T, Heutink P (1998) Association of missense and 5′-splice site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705
61. Dumanchin C, Camuzat A, Campion D, Verpillat P, Hannequin D, Dubois B, Saugier-Veber P, Martin C, Penet C, Charbonnier F, Agid Y, Frebourg T, Brice A (1998) Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum Mol Genet 7:1825-1829
62. Clark LN, Poorkaj P, Wszolek Z, Geschwind DH, Nasreddine ZS, Miller B, Li D, Payamin H, Awert F, Markopoulou K, Andreadis A, D'Souza I, Lee VM-Y, Reed L, Trojanowski JQ, Zhukareva V, Bird T, Schellenberg G, Wilhelmsen KC (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A 95:13103-13107
63. Hutton M (2001) Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms. Neurology 56 [Suppl 4]:S21-S25
64. Reed LA, Wszolek ZK, Hutton M (2001) Phenotypic correlations in FTDP-17. Neurobiol Aging 22:89-107
65. Chow T, Miller B, Hayashi V, Geschwind DH (1999) Inheritance of frontotemporal dementia. Arch Neurol 56:817-822
66. Stevens M, Duijn CM van, Kamphorst W, Knijff P de, Heutink P, Gool WA van, Scheltens P, Ravid R, Oostra BA, Niermeijer MF, Swieten JC Van (1998) Familial aggregation in frontotemporal dementia. Neurology 50:1541-1545
67. Rizzu P, Swieten JC Van, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, Duijn CM van, Heutink P (1999) High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 64:414-421
68. Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, Hutton M (1999) Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol. 46:243-248
69. Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M, Ozansoy M, Hardy J, Hutton M, Wood NW, Lees AJ, Revesz T, Lantos P, Rossor MN (2001) The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol 58:1813-1816
70. Neary D, Snowden JS, Mann DM (2000) Classification and description of frontotemporal dementias. Ann N Y Acad Sci 920:46-51
71. Constantinidis J, Richard J, Tissot R (1974) Pick's disease. Histological and pathological correlations. Eur Neurol 11: 208-217
72. Constantinidis J (1985) Pick dementia. Anatomoclinical correlations and pathophysiological considerations. In: Rose FC (ed) Modern Approaches to the Dementias. I. Etiology and Pathophysiology. Interdisciplinary Topics in Gerontology, vol. 19. Karger, Basel, Switzerland, pp 72-97
73. Knopman DS, Mastri AR, Frey WH II, Sung J, Rustan T (1990) Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia. Neurology 40:251-256
74. Knopman DS (1993) Overview of dementia lacking distinctive histology: Pathological designation of a progressive dementia. Dementia 4:132-136
75. Giannakopoulos P, Hof PR, Bouras C (1995) Dementia lacking distinctive histopathology: Clinicopathological evaluation of 32 cases. Acta Neuropathol (Berl) 89:346-355
76. Jackson M, Lowe J (1996) The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol (Berl) 91:127-134
77. Tolnay M, Probst A (1995) Frontal lobe degeneration: Novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21:492-497
78. Kinoshita A, Tomimoto H, Tachibana N, Suenaga T, Kawamata T, Kimura T, Akiguchi I, Kimura J (1996) A case of primary progressive aphasia with abnormally ubiquitinated neurites in the cerebral cortex. Acta Neuropathol (Berl) 92:520-524
79. Rossor MN, Revesz T, Lantos PL, Warrington EK (2000) Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 123:267-276
80. Schwarz M, De Bleser R, Poeck K, Weis J (1998) A case of primary progressive aphasia. A 14-year follow-up study with neuropathological findings. Brain 121:115-126
81. Mitsuyma Y, Takamiya S (1979) Presenile dementia with motor neuron disease in Japan. A new entity? Arch Neurol 36:592-593
82. Neary D, Snowden JS, Mann DM, Northen B, Goulding PJ, Macdermott N (1990) Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 53:23-32
83. Okamoto K, Hirai S, Yamazaki Y, Sun X, Nakazato Y (1991) New ubiquitin-positive intraneuronal inclusions in the extramotor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 129:233-236
84. Wightman G, Anderson VE, Martin J, Swash M, Anderton BH, Neary D, Mann D, Luthert P, Leigh PN (1992) Hippocampal and neocortical ubiquitin immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett 139:269-274
85. Jackson M, Lennox G, Lowe J (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5:339-350
86. Woulfe J, Kertesz A, Munoz DG (2001) Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol (Berl) 102:94-102
87. Rosso MS, Kamphorst W, Graaf B de, Willemsen R Ravid R, Niermeijer MF, Spillantini MG, Heutink P, Swieten JC Van (2001) Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 124:1948-1957
88. Kinoshita A, Tomimoto H, Suenaga T, Akiguchi I, Kimura J (1997) Ubiquitin-related cytoskeletal abnormality in frontotemporal dementia: Immunohistochemical and immunoelectron microscope studies. Acta Neuropathol (Berl) 94: 67-72
89. Iseki E, Li F, Odawara T, Hino H, Suzuki K, Kosaka K, Akiyama H, Ikeda K, Kato M (1998) Ubiquitin-immunohistochemical investigation of atypical Pick's disease without Pick bodies. J Neurol Sci 159:194-201
90. Layfield R, Alban A, Mayer RJ, Lowe J (1999) The ubiquitin protein catabolic disorders. Neuropathol Appl Neurobiol 27: 171-179
91. Lowe J, Mayer J, Landon M, Layfield R (2001) Ubiquitin and the molecular pathology of neurodegenerative diseases. Adv Exp Med Biol 487:169-186
92. Noda K, Katayama S, Watanabe C, Yamamura Y, Nakamura S (1999) Gallyas- and tau-positive glial structures in motor neuron disease with dementia. Clin Neuropathol 18:218-225
93. Forno LS, Langston JW, Herrick MK, Wilson JD, Murayama S (2002) Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type. Acta Neuropathol (Berl) 103:599-606
94. Bak TH, Hodges JR (2001) Motor neurone disease, dementia and aphasia: Coincidence, co-occurrence or continuum? J Neurol 248:260-270
95. Gunnarson LG, Dahlbom K, Strandman E (1991) Motor neuron disease and dementia reported among 13 members of a single family. Acta Neurol Scand 84:429-433
96. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE, Gallo JM, Weller RO, Anderton BH (1991) Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution and specificity. Brain 114:775-788
97. Anderson VE, Cairns NJ, Leigh PN (1995) Involvement of the amygdala, dentate and hippocampus in motor neuron disease. J Neurol Sci 129 [Suppl]:75-78
98. Kawashima T, Doh-ura K, Kikuchi H, Iwaki T (2001) Cognitive dysfunction in patients with amyotrophic lateral sclerosis is associated with spherical or crescent-shaped ubiquitinated intraneuronal inclusions in the parahippocampal gyrus and amygdala, but not in the neostriatum. Acta Neuropathol (Berl) 102:467-472
99. Cooper PN, Jackson M, Lennox G, Lowe J, Mann DM (1996) Brain-stem inclusions in motor neuron disease-type dementia. Arch Neurol 53:836
100. Holton JL, Révész T, Crooks R, Scaravilli F (2002) Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl) 103:221-227
101. Ince PG, Lowe J, Shaw PJ (1998) Amyotrophic lateral sclerosis: Current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 24:104-117
102. Brown J, Ashworth A, Gydesen S, Sorenson A, Rossor M, Hardy J, Collinge J (1995) Familial non-specific dementia maps to chromosome 3. Hum Mol Genet 4:1625-1628
103. Ashworth A, Lloyd S, Brown J, Gydesen S, Sorensen SA, Brun A, Englund E, Humphreys C, Housman D, Badura M, Stanton V Jr, Taylor K, Cameron J, Munroe D, Johansson J, Rossor M, Fisher EMC, Collinge J (1999) Molecular genetic characterisation of frontotemporal dementia on chromosome 3. Dement Geriatr Cogn Disord 10 [Suppl 1}:93-101
104. Lendon CL, Lynch T, Norton J, McKeel DW Jr, Busfield F, Craddock N, Chakraverty S, Gopalakrishnan G, Shears SD, Grimmett W, Wilhelmsen KC, Hansen L, Morris JC, Goate AM (1998) Hereditary dysphasic disinhibition dementia: A frontotemporal dementia linked to 17q21-22. Neurology 50:1546-1555
105. Zhukareva V, Vogelsberg-Ragaglia V, Deerlin VM Van, Bruce J, Shuck T, Grossman M, Clark CM, Arnold SE Masliah E, Galasko D, Trojanowski JQ, Lee VM-Y (2001) Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 49:165-175
106. Adamec E, Chang HT, Stopa EG, Hedreen JG, Vonsattel JP (2001) Tau protein expression in frontotemoral dementias. Neurosci Lett 315:21-24
107. Froelich S, Basun H, Forsell C, Lilius L, Axelman K, Andreadis A, Lannfelt L (1997) Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. Am J Med Genet 74:380-385
108. Basun H, Almkvist O, Axelman K, Brun A, Campbell TA, Collinge J, Forsell C, Froelich S, Wahlund L-O, Wetterberg L, Lannfelt L (1997) Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia. Arch Neurol 54:539-544
109. Brown J, Lantos P, Rossor M (1998) Familial dementia lacking specific pathological features of corticobasal degeneration. J Neurol Neurosurg Psychiatry 65:600-603
110. Boeve BF, Maraganore DM, Parisi JE, Ivnik RJ, Westmoreland BF, Dickson DW, Hutton M, Hardy J, Caselli, RJ, Petersen RC (2002) Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dement Geriatr Cogn Disord 13:80-90
111. Heutink P, Stevens M, Rizzu P, Bakker E, Kros JM, Tibben A, Niermeijer MF, Duijn CM van, Oostra BA, Swieten JC van (1997) Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: A genetic and clinicopathological study of three Dutch families. Ann Neurol 41:150-159
112. Kertesz A, Kawarai T, Rogaeva E, St. George-Hyslop P, Poorkaj P, Bird TD, Munoz DG (2000) Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54:818-827
113. Savioz A, Kövari E, Anastasiu R, Rossier C, Saini K, Bouras C, Leuba G (2000) Search for a mutation in the tau gene in a Swiss family with frontotemporal dementia. Exp Neurol 161:330-335
114. Kövari E, Leuba G, Savioz A, Saini K, Anastasiu R, Miklossy J, Bouras C (2000) Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol (Berl) 100:421-426
115. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung W-Y, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH Jr (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 284:1664-1669
116. Kimonis VE, Kovach MJ, Waggoner B, Leal S, Salam A, Rimer L, Davis K, Khardori R, Gelber D (2000) Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med 2:232-241
117. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA, Shanks CA, Gregg G, Al-Lozi MT, Miller T, Rakowicz W, Lopate G, Florence J, Glosser G, Simmons Z, Morris JC, Whyte MP, Pestronk A, Kimonis VE (2001) Clinical delineation and localization to chromosome 9p13.3p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 74:458-475
118. Haass C, De Strooper B (1999) The presenilins in Alzheimer's disease - Proteolysis holds the key. Science 286:916-919
119. Raux G, Gantier R, Thomas-Anterion C, Boulliat J, Verpillat P, Hannequin D, Brice A, Frebourg, T, Campion D (2000) Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation. Neurology 55:1577-1578
120. Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E, Rogaev EI, Frommelt P, Sadovnick AD, Meschino W, Rockwood K, Boss MA, Mayeux R, St George-Hyslop P (2001) Screening for PS1 mutations in a referral-based series of AD cases: 21 Novel mutations. Neurology 57:621-625
121. Amtul Z, Lewis PA, Piper S, Crook R, Baker M, Findlay K, Singleton A, Hogg M, Younkin L, Younkin SG, Hardy J, Hutton M, Boeve BF, Tang-Wai D, Golde TE (2002) A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiol Dis 9:269-273
122. Hardy J (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159
123. Evin G, Smith MJ, Tziotis A, McLean C, Canterford L, Sharples RA, Cappai R, Weidemann A, Beyreuther K, Cotton RGH, Masters CL, Culvenor JG (2002) Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Neuroreport 13:917-921
124. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:550-553
125. Tolnay M, Spillantini MG, Rizzini C, Eccles D, Lowe J, Ellison D (2000) A new case of frontotemporal dementia and parkinsonism resulting from an intron 10 +3-splice site mutation in the tau gene: Clinical and pathological features. Neuropathol Appl Neurobiol 26:368-378